The company is a Korea-based company principally engaged in the bioinformatics analysis business. The Company is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. It is also engaged personal genetic testing, software development, rental business and others. The Company was established on April 20, 2018. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 8, 2021.
Headquarters
4-5F Kdu Tower, 70 Jeongui-Ro, Songpa-Gu
Seoul; Seoul;
Contact Details: Purchase the Geninus Inc. report to view the information.
Website: http://kr-geninus.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service